Hematologic Improvement–Neutrophil and –Platelet in the MEDALIST Trial: Multilineage Data from a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Luspatercept to Treat Anemia in Patients with Very Low-, Low-, or Intermediate-Risk Myelodysplastic Syndromes (MDS) with Ring Sideroblasts (RS) Who Require Red Blood Cell (RBC) Transfusions

---

Guillermo G., hulam J. M., Pierre F., Valeria S., Mara Dez C., Carlo F., ...Daha Fazla

ASH2019, 7 - 10 Aralık 2019, (Tam Metin Bildiri)

• Yayın Türü: Bildiri / Tam Metin Bildiri
• Lokman Hekim Üniversitesi Adresli: Evet